Lir Therapeutics,
transforming enemies to allies.

Post-COVID, viruses became shorthand for fear and stigma, and competitors tiptoed around the “V-word.” The science
was sound, but the story was broken.

Meet LIR, a company at the forefront of viral engineering.
Their founders had spent their careers designing safer,
more efficient vectors — yet their technology was being overshadowed by fear.

We didn’t build them a safer brand. We built them a braver one. The Good Virus Company became their rallying cry, bold enough to turn stigma into strength while underscoring their leadership in the next generation of gene therapy. The result was more than a brand shift. It was a cultural reset: from fear
to trust, from avoidance to leadership.